Effect of Diprotin A, an Inhibitor of Dipeptidyl Peptidase IV, on Immunological Parameters of Lymphocytes in Intact Animals and Animals with Experimental Autoimmune Process

Verfasser / Beitragende:
[M. Robinson, E. Mel'nikova, V. Trufakin]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/6(2015-04-01), 769-771
Format:
Artikel (online)
ID: 605537461
LEADER caa a22 4500
001 605537461
003 CHVBK
005 20210128100857.0
007 cr unu---uuuuu
008 210128e20150401xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2858-0  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2858-0 
245 0 0 |a Effect of Diprotin A, an Inhibitor of Dipeptidyl Peptidase IV, on Immunological Parameters of Lymphocytes in Intact Animals and Animals with Experimental Autoimmune Process  |h [Elektronische Daten]  |c [M. Robinson, E. Mel'nikova, V. Trufakin] 
520 3 |a We found the peculiarities of the effects of dipeptidyl peptidase IV inhibitor diprotin A on immunological parameters of lymphocytes in lymphoid organs in intact animals and in animals with experimental autoimmune process. In intact animals, diprotin A increased cellularity of the thymus and spleen, number of CD4+, CD8+, and CD4+8+ thymocytes and CD3+ splenocytes and reduced cellularity of lymph nodes and the number of antibody-forming cells in the spleen. Diprotin A administered against the background of autoimmune process, reduced thymus cellularity, number of antibody-forming cells in the spleen, and number of CD4 and CD4+8+ thymocytes in comparison with the corresponding parameters of autoimmune process. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a lymphocyte  |2 nationallicence 
690 7 |a diprotin A  |2 nationallicence 
690 7 |a experimental autoimmune process  |2 nationallicence 
700 1 |a Robinson  |D M.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
700 1 |a Mel'nikova  |D E.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
700 1 |a Trufakin  |D V.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/6(2015-04-01), 769-771  |x 0007-4888  |q 158:6<769  |1 2015  |2 158  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2858-0  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2858-0  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Robinson  |D M.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Mel'nikova  |D E.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Trufakin  |D V.  |u Research Institute of Clinical and Experimental Lymphology, Siberian, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/6(2015-04-01), 769-771  |x 0007-4888  |q 158:6<769  |1 2015  |2 158  |o 10517